133 related articles for article (PubMed ID: 3107028)
1. BM-5, a centrally active partial muscarinic agonist with low tremorogenic activity. In vivo and in vitro studies.
Engström C; Undén A; Ladinsky H; Consolo S; Bartfai T
Psychopharmacology (Berl); 1987; 91(2):161-7. PubMed ID: 3107028
[TBL] [Abstract][Full Text] [Related]
2. Regional differences in receptor reserve for analogs of oxotremorine in vivo: implications for development of selective muscarinic agonists.
Ringdahl B; Roch M; Jenden DJ
J Pharmacol Exp Ther; 1987 Aug; 242(2):464-71. PubMed ID: 3612545
[TBL] [Abstract][Full Text] [Related]
3. The pharmacological assessment of RS 86 (2-ethyl-8-methyl-2,8-diazaspiro-[4,5]-decan-1,3-dion hydrobromide). A potent, specific muscarinic acetylcholine receptor agonist.
Palacios JM; Bolliger G; Closse A; Enz A; Gmelin G; Malanowski J
Eur J Pharmacol; 1986 Jun; 125(1):45-62. PubMed ID: 3732391
[TBL] [Abstract][Full Text] [Related]
4. Muscarinic actions and receptor binding of the enantiomers of BM 130, an alkylating analog of oxotremorine.
Ringdahl B; Katz ED; Roch M; Jenden DJ
J Pharmacol Exp Ther; 1989 Apr; 249(1):210-5. PubMed ID: 2709331
[TBL] [Abstract][Full Text] [Related]
5. Urea and 2-imidazolidone derivatives of the muscarinic agents oxotremorine and N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide.
Nilsson BM; Vargas HM; Hacksell U
J Med Chem; 1992 Aug; 35(17):3270-9. PubMed ID: 1507212
[TBL] [Abstract][Full Text] [Related]
6. Dual effect of N-methyl-N-(1-methyl-4-pyrolidino)-2-butyl)acetamide on release of (3H)-acetylcholine from the rat hippocampal slices.
Sethy VH; Francis JW; Russell RR; Ruppel PL
Neuropharmacology; 1988 Nov; 27(11):1191-5. PubMed ID: 3205386
[TBL] [Abstract][Full Text] [Related]
7. Stereoselective binding and activity of oxotremorine analogs at muscarinic receptors in rat brain.
Messer WS; Ngur DO; Abuh YF; Dokas LA; Ting SM; Hacksell U; Nilsson BM; Dunbar PG; Hoss W
Chirality; 1992; 4(8):463-8. PubMed ID: 1476855
[TBL] [Abstract][Full Text] [Related]
8. Muscarinic actions of an N-methyl-N-2-bromoethylamino analog of oxotremorine (BR 401) in the mouse.
Ringdahl B; Jenden DJ
J Pharmacol Exp Ther; 1987 Feb; 240(2):370-5. PubMed ID: 3806401
[TBL] [Abstract][Full Text] [Related]
9. Conformationally restricted analogues of the muscarinic agent N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide.
Lundkvist JR; Ringdahl B; Hacksell U
J Med Chem; 1989 Apr; 32(4):863-9. PubMed ID: 2704032
[TBL] [Abstract][Full Text] [Related]
10. 5-Methyl-2-pyrrolidone analogues of oxotremorine as selective muscarinic agonists.
Ringdahl B
J Med Chem; 1988 Mar; 31(3):683-8. PubMed ID: 3346881
[TBL] [Abstract][Full Text] [Related]
11. Presynaptic antagonist-postsynaptic agonist at muscarinic cholinergic synapses. N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide.
Nordström O; Alberts P; Westlind A; Undén A; Bartfai T
Mol Pharmacol; 1983 Jul; 24(1):1-5. PubMed ID: 6306436
[TBL] [Abstract][Full Text] [Related]
12. Effect of BM-5, a presynaptic antagonist-postsynaptic agonist, on cortical acetylcholine release.
Casamenti F; Cosi C; Pepeu G
Eur J Pharmacol; 1986 Mar; 122(2):288-90. PubMed ID: 3011445
[TBL] [Abstract][Full Text] [Related]
13. Serotonergic potentiation of muscarinic agonist evoked tremor and salivation in rat and mouse.
Ogren SO; Carlsson S; Bartfai T
Psychopharmacology (Berl); 1985; 86(3):258-64. PubMed ID: 3929296
[TBL] [Abstract][Full Text] [Related]
14. Chemical and biochemical studies of 2-propynylpyrrolidine derivatives. Restricted-rotation analogues of N-methyl-N-(1-methyl-4-pyrrolidino-2-butynyl)acetamide (BM-5).
Trybulski EJ; Kramss RH; Mangano RM; Rusinko A
J Med Chem; 1990 Dec; 33(12):3190-8. PubMed ID: 2258905
[TBL] [Abstract][Full Text] [Related]
15. Behavioral and physiological effects associated with changes in muscarinic receptors following administration of an irreversible cholinergic agonist (BM 123).
Russell RW; Smith CA; Booth RA; Jenden DJ; Waite JJ
Psychopharmacology (Berl); 1986; 90(3):308-15. PubMed ID: 3097716
[TBL] [Abstract][Full Text] [Related]
16. Novel alkoxy-oxazolyl-tetrahydropyridine muscarinic cholinergic receptor antagonists.
Shannon HE; Bymaster FP; Hendrix JC; Quimby SJ; Mitch CH
Psychopharmacology (Berl); 1995 Jan; 117(2):208-15. PubMed ID: 7753969
[TBL] [Abstract][Full Text] [Related]
17. The pharmacological assessment of a new, potent oxotremorine analogue in mice and rats.
Resul B; Lewander T; Ringdahl B; Zetterström T; Dahlbom R
Eur J Pharmacol; 1982 May; 80(2-3):209-15. PubMed ID: 7106176
[TBL] [Abstract][Full Text] [Related]
18. Chronic scopolamine treatment and brain cholinergic function.
Marks MJ; O'Connor MF; Artman LD; Burch JB; Collins AC
Pharmacol Biochem Behav; 1984 May; 20(5):771-7. PubMed ID: 6739517
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vivo effects of parathion on striatal acetylcholine accumulation in adult and aged rats.
Karanth S; Liu J; Ray A; Pope C
Toxicology; 2007 Oct; 239(3):167-79. PubMed ID: 17707571
[TBL] [Abstract][Full Text] [Related]
20. Xanomeline: a novel muscarinic receptor agonist with functional selectivity for M1 receptors.
Shannon HE; Bymaster FP; Calligaro DO; Greenwood B; Mitch CH; Sawyer BD; Ward JS; Wong DT; Olesen PH; Sheardown MJ; Swedberg MD; Suzdak PD; Sauerberg P
J Pharmacol Exp Ther; 1994 Apr; 269(1):271-81. PubMed ID: 7909557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
